Michel Goedert

Michel Goedert is a prominent neuroscientist and researcher who currently serves as the Head of the Division of Neurobiology at the Medical Research Council (MRC) Laboratory of Molecular Biology in Cambridge, UK.12 His work primarily focuses on investigating the molecular mechanisms of neurodegeneration.1

Research Focus

Goedert's research is centered on understanding neurodegenerative diseases, with a particular emphasis on:

• Amyloid-β filaments in Alzheimer's disease
• α-synuclein aggregation in Parkinson's disease and multiple system atrophy
• Tau protein in frontotemporal dementia and other tauopathies

His team has made significant contributions to the field, including:

• Cryo-EM structures of amyloid-β 42 filaments from human brains1
• Studies on the assembly of α-synuclein and its role in neurodegeneration1
• Investigations into seeded assembly of α-synuclein filaments in multiple system atrophy1

Achievements and Recognition

Goedert's work has been widely recognized in the scientific community. Some notable achievements include:

• Receiving the 2023 Annemarie Opprecht Parkinson Award, along with his colleague Sjors Scheres3
• Publishing numerous high-impact papers in prestigious journals such as Nature, Science, and eLife1

Professional Network

As the Head of the Division of Neurobiology at the MRC, Goedert leads a team of researchers and collaborates with scientists worldwide. His LinkedIn profile indicates that he has over 1,000 followers and more than 500 connections in the scientific community.2

Michel Goedert's contributions to the field of neurodegenerative disease research have significantly advanced our understanding of the molecular mechanisms underlying conditions such as Alzheimer's and Parkinson's diseases, making him a key figure in the neuroscience research community.